HoxA3 is an apical regulator of haemogenic endothelium. by Iacovino, Michelina et al.
UCLA
UCLA Previously Published Works
Title
HoxA3 is an apical regulator of haemogenic endothelium.
Permalink
https://escholarship.org/uc/item/6sq0d5gr
Journal
Nature cell biology, 13(1)
ISSN
1465-7392
Authors
Iacovino, Michelina
Chong, Diana
Szatmari, Istvan
et al.
Publication Date
2011
DOI
10.1038/ncb2137
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
HoxA3 is an apical regulator of hemogenic endothelium
Michelina Iacovino1, Diana Chong2, Istvan Szatmari1, Lynn Hartweck1, Danielle Rux1, 
Arianna Caprioli2, Ondine Cleaver2, and Michael Kyba1
1Lillehei Heart Institute and Department of Pediatrics, University of Minnesota, Minneapolis, MN
2Department of Molecular Biology, UT Southwestern Medical Center, Dallas, TX
Keywords
hemogenic endothelium; hematopoiesis; dorsal aorta; Hox genes; HoxA3; hemangioblast
During development, hemogenesis occurs invariably at sites of vasculogenesis. Between 
E9.5 and E10.5 in mouse, endothelial cells in the caudal portion of the dorsal aortae generate 
hematopoietic stem cells 1, 2 and are referred to as hemogenic endothelium 3-8. The 
mechanisms by which hematopoiesis is restricted to this domain, and how the morphological 
transformation from endothelial to hematopoietic is controlled are unknown. We show here 
that HoxA3, a gene uniquely expressed in the embryonic but not yolk sac vasculature, 
restrains hematopoietic differentiation of the earliest endothelial progenitors, and reverts the 
earliest hematopoietic progenitors into CD41-negative endothelial cells. This reversible 
modulation of endothelial-hematopoietic state is accomplished by targeting key 
hematopoietic transcription factors for downregulation, including Runx1, Gata1, Gfi1B, 
Ikaros, and PU.1. Through loss-of-function, and gain-of-function epistasis experiments and 
the identification of antipodally regulated targets, we show that among these factors, Runx1 
is uniquely able to erase the endothelial program set up by HoxA3. These results suggest 
both why a frank endothelium does not precede hematopoiesis in the yolk sac and why 
hematopoietic stem cell generation requires Runx1 expression only in endothelial cells.
Homeobox genes play an important role during vertebrate development, determining cell 
identity along the rostral-caudal axis. In early development, they are expressed along this 
axis in a manner colinear with their order within the Hox cluster 9. In some tissues, these 
rostral-caudal expression patterns are reset during organogenesis; for example, several Hox 
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genes have been identified in hematopoietic stem cells, and the expression patterns change 
with differentiation 10-13. The expression of members of Hox paralog group 4, including 
HoxB4, promotes self-renewal of the HSC 14-16 and allows engraftment of early embryonic 
hematopoietic progenitors produced in vitro from ES cells 17. Hox paralog group 3, the next 
anterior, is best known for specifying the identity of tissues that originate from the 
pharyngeal arches, however it also plays an important role in endothelial development. Mice 
lacking HoxA3 display cardiovascular abnormalities 18 and vascular expression of paralog 
group 3 members is associated with angiogenesis and wound repair 19-21. Growing evidence 
suggests that the embryonic vasculature gives rise to hematopoietic progenitors via a 
specialized hemogenic endothelium 3, 22, 23. The posterior dorsal aorta is such a specialized 
site that plays a particularly important role in the origin of the adult HSC pool through a 
poorly understood process that is dependent on Runx1 5. The vascular role of paralog group 
3 prompted us to evaluate the temporal expression of HoxA3 in the hemogenic domains of 
the dorsal aorta. In early development (E7.5), HoxA3 expression is restricted to the embryo 
proper, while Runx1 expression marks hematopoiesis in the yolk sac (Sup. Fig. 1A, B). 
HoxA3 and Runx1 display a remarkable pattern of mutually exclusive expression at 
hematopoietic/vascular sites in the early embryo. At E8.25 and E8.5, HoxA3 is highly 
expressed throughout the neurectoderm and mesenchyme, is present at intermediate levels in 
the endothelium of both the anterior and posterior dorsal aortae, and remains absent from the 
yolk sac (Fig. 1A, C and Sup. Fig. 1C, E). By contrast, Runx1 is found in the yolk sac but 
not in the aortae or other embryonic vessels (Fig. 1B, D and Sup. Fig. 1D, F) with the 
exception of the omphalomesenteric artery, as seen previously 24, 25. Notably, HoxA3 is not 
expressed in the omphalomesenteric artery (Fig. 1C). At E9.5, and E10.5 the time point at 
which the posterior dorsal aortae first begin to express Runx1 and become hemogenic, 
HoxA3 expression is clearly lost in the aortic endothelial cells (Fig. 1E, G Sup. Fig. 1G, I), 
while Runx1 is expressed (Fig. 1F, H, Sup. Fig 1H,J).
HoxA3 down-regulation thus marks the site of hemogenesis in the endothelium of the dorsal 
aorta. Does HoxA3 expression have any functional effect on the development of hemogenic 
endothelium? In order to answer this question, we generated a doxycycline (dox)-inducible 
HoxA3 murine ES cell line by cassette exchange recombination into a dox-inducible locus 
16
 and differentiated these cells as embryoid bodies (EBs). The kinetics of mesoderm 
differentiation in this system broadly mimics that of embryonic development 26 with 
bipotent hematopoietic-endothelial progenitors (hemangioblasts) identified in clonal assays 
as early as 2.75 days of differentiation 27, corresponding to embryonic bipotent progenitors 
of the posterior primitive streak, thought to contribute to yolk sac hematopoiesis 28. 
Vascular markers, eg. VE-cadherin, Tie2, and CD31, first appear two days later, 
coexpressed on many cells with the earliest hematopoietic marker, CD41 29, 30. The 
coexpressing population is capable of both endothelial and hematopoietic differentiation, 
thus defining it as hemogenic endothelium 31, 32. When we induced HoxA3 with dox just 
before this time (day 4-6), we noted a striking repression of the hematopoietic markers 
CD41+ and CD45+ (Fig. 2A, B). However, the total endothelial progenitor population 
identified as cells expressing both Flk1 and VE-cadherin 33, 34 (F/V population) was not 
reduced by HoxA3 expression (Fig. 2A, B). We assayed hematopoietic progenitor content in 
these EBs and found that HoxA3 dramatically suppressed hematopoietic colony-forming 
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cell (CFC) content, (Fig. 2C) demonstrating that HoxA3 is not merely preventing expression 
of surface markers, but truly preventing hematopoietic differentiation. When hematopoietic 
progenitors (c-Kit CD41 double-positive cells) from uninduced EBs were sorted and plated 
in CFC assays, HoxA3 expression in the methylcellulose medium abolished hematopoietic 
colony-forming potential (Sup. Fig. 2A). To determine whether the hematopoietic repression 
of HoxA3 was due to cell death or a change in cell fate, hematopoietic (c-Kit+/CD41+; K/
41), and endothelial (Flk1+/VE-cadherin+; F/V) fractions were purified from day 6 EBs and 
cultured on OP9 stromal cells, a system that support both hematopoiesis and endothelial 
development. In the absence of doxycycline both the F/V and K/41 fractions produced 
hematopoietic cells, consistent with the notion that the endothelial fraction is endowed with 
hemogenic capacity 32 (Fig. 2F, G, no dox). However when HoxA3 was upregulated, 
hematopoietic marker expression was significantly reduced (Figure 2F G, + dox). 
Remarkably, in the presence of doxycycline, not only were hematopoietic cells missing from 
the K/41 fraction, but colonies of cells with an epithelial morphology and expressing VE-
cadherin were observed instead (Fig. 2E). The induction of endothelial markers and 
repression of hematopoietic markers was seen also in more committed progenitors already 
expressing the pan-hematopoietic marker CD45 (Sup. Fig. 2B). When HoxA3 expression 
was withdrawn, hematopoietic colonies developed again, in both K/41 and F/V-initiated 
cultures (Fig. 2D-G). This result shows that HoxA3 restrains hematopoietic development 
and maintains an endothelium, even in progenitors that have recently committed to 
hematopoiesis, indicated by expression of CD41 and CD45.
To test the effect of HoxA3 in bona fide hemogenic endothelium 6-8, we expressed HoxA3 
with an ires-GFP reporter by retroviral transduction in disaggregated E10.5 AGM tissue 
cultured ex vivo. Both GFP+ hematopoietic and GFP+ adherent colonies could be detected 
in cultures transduced with control vector, however with the HoxA3 vector, only GFP-
negative hematopoietic colonies were found while GFP+ colonies were adherent (Figure 
2H). Flow cytometric analysis confirmed that cells expressing HoxA3 had elevated Flk-1 
and VE-cadherin expression, and reduced CD41 and CD45 expression (Fig. 2I). Thus 
HoxA3 is able to repress hematopoietic development in both ES-derived hematopoieitic 
progenitors and in embryonic AGM-derived tissue.
To gain insight into the mechanism by which HoxA3 regulates the hemogenic transition we 
performed transcriptional profiling on both the endothelial and hematopoietic progenitor 
fractions from day 6 EBs treated with doxycycline for 6 hours (Fig. 3). In the hematopoietic 
(K/41) fraction HoxA3 regulated 585 genes of which 277 were repressed and 308 were 
upregulated (1.5 fold p-value 0.05 cut-off Fig. 3A). Because HoxA3 promotes the 
endothelial phenotype in this fraction and inhibits hematopoiesis, we evaluated HoxA3 
upregulated genes based on their expression in control hematopoietic or endothelial 
fractions. Genes involved in endothelial development clustered together, were expressed at 
higher levels in the control F/V fraction compared to the control K/41 fraction, and were 
generally upregulated by HoxA3 in the dox-treated K/41 fraction (Fig. 3B). We performed a 
similar analysis for the F/V fraction in which 832 genes were regulated (421 down and 411 
up; 1.5 fold cut off p-value 0.05, Fig 3A). Genes repressed by HoxA3 included many known 
hematopoietic regulators most of which are expressed at higher levels in control K/41 cells 
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compared to control F/V cells (Fig. 3C). Within this cluster HoxA3 significantly repressed 
the expression of Runx1, Gata1, Gfi1B, Ikaros and Phemx and PU.1, all validated by qPCR 
(Fig. 3D). HoxA3 thus coordinately regulates a large number of genes involved in 
endothelial and hematopoietic development, preventing the hematopoietic program from 
arising in endothelial progenitors and reactivating an endothelial program in nascent 
hematopoietic progenitors. It is the first regulatory factor identified to date to have this 
effect.
One of the notable downregulated targets is Runx1. Loss of function analysis of Runx1 
demonstrated it to be essential for definitive hematopoiesis 35, 36 and for the emergence of 
hematopoietic cells from the aorta 24. Conditional deletion of Runx1 has shown that its role 
is essential in VE-cadherin-positive cells of the aorta, but dispensable in the (Vav-1-
expressing) hematopoietic stem cells themselves 5. To determine the functional relevance of 
Runx1 and other hematopoietic transcription factors repressed by HoxA3, we performed 
dominant epistasis experiments. Endothelial (F/V) progenitor cells from HoxA3-induced 
EBs were sorted and transduced with Runx1B, Ikaros, Pu.1, Gata1, Gfi1B, or control vectors 
bearing ires-GFP reporters, and cultured on OP9 stroma. Surface marker analysis of GFP-
gated cells demonstrated that Runx1 strongly suppressed, GATA1 partially suppressed, and 
Gfi1B minimally suppressed the HoxA3 phenotype, while Pu.1 and Ikaros had no effect 
(Fig. 4A,B). Transcriptional analysis showed that Gfi1B, PU.1, Ikaros, and Phemx, were 
actually target genes of Runx1, but that GATA1 was not (Fig. 4C). To understand this 
epistasis, we sorted Runx1- or GATA1- transduced, HoxA3-expressing cells, and 
determined their global gene expression profiles in comparison to HoxA3-expressing cells 
(with control GFP vector), or cells in which HoxA3 expression was turned off by 
doxycycline withdrawal. Consistent with their ability to revert the HoxA3 phenotype, high 
level overexpression of both Runx1 and GATA1 reverted many of the gene expression 
changes induced by HoxA3, particularly those genes that were repressed by HoxA3, 
including Gfi1B and other hematopoietic transcription factors (Fig. 4D). However, Runx1 
was more potent than GATA1 in repressing genes that were upregulated by HoxA3, 
including many key endothelial regulatory factors, as well as regulators of adhesion and 
polarity (Fig 4E).
We tested putative HoxA3 recognition sequences within the Runx1 locus by ChIP and found 
that several, including a conserved sequence upstream of the P2 enhancer, were sites of 
direct binding (Sup. Fig. 3A,B). We then tested whether the loss of HoxA3 would lead to 
derepression of Runx1 in vivo by performing in situ hybridization with Runx1 probe on 
HoxA3 mutant embryos 37. At E8.5, Runx1 expression was never detected in the dorsal 
aortae of wild-type (0/24) or heterozygous (0/41) embryos, however in a significant number 
of null embryos (14/29), we observed precocious expression of Runx1 in endothelial cells of 
the dorsal aorta, and occasionally in excess hematopoietic cells within the aortic lumen (Fig. 
5A), demonstrating that HoxA3 represses Runx1 in vivo.
These data demonstrate that HoxA3 sits at the apex of a cascade of regulatory factors, such 
that the spatiotemporal regulation of HoxA3 expression determines where and when 
hemogenic potential arises within embryonic vessels. HoxA3 represses hemogenesis in part 
by blocking the expression of Runx1, which would otherwise activate numerous 
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downstream transcription factors to promote hematopoietic development. This finding has 
implications for the two modes of hematopoiesis in early embryonic development: yolk sac 
mesoderm, which does not express HoxA3, undergoes synchronous hematopoietic and 
endothelial differentiation, while hematopoietic differentiation from lateral plate mesoderm, 
which expresses HoxA3, is delayed, and occurs by budding from a well-defined 
endothelium. It is notable that Runx1 was shown to be required only transiently, and in the 
endothelial cells, not the derived hematopoietic cells, of the AGM 5. The expression profile 
of cells expressing both HoxA3 and Runx1 indicates that an essential role of Runx1 is to 
extinguish an endothelial program. This is a transient requirement, and not necessary in the 
yolk sac where endothelial and hematopoietic cells develop concurrently, not sequentially, 
but required in the AGM where hematopoietic cells emerge from an endothelium. Our 
model is summarized in Fig. 5B: endothelial progenitors produced in lateral plate mesoderm 
are inhibited from further differentiation towards hematopoeisis by HoxA3 which represses 
Runx1 together with other key hematopoietic transcription factors. HoxA3 is then 
extinguished within a subset of endothelium, allowing hemogenesis to occur. Although the 
presence of a hemogenic endothelium has been appreciated for almost a century 38, the 
spatiotemporal patterning of the embryonic endothelium into hemogenic and non-hemogenic 
domains, and the regulation of the endothelial-hematopoietic transition have remained 
inscrutable. The data presented here demonstrates that HoxA3 plays a critical role in both 
processes by acting as a gatekeeper at the apex of the transcriptional hierarchy restricting 
entry into the hematopoietic program.
Methods Summary
HoxA3 inducible ES cell generation culture and in vitro differentiation
HoxA3 cDNA (Y11717) was a gift from Dr Sarah Guthrie 39 and was subcloned into p2Lox, 
the targeting vector for the A2Lox ES cell line 16. HoxA3 inducible ES cells were generated 
by cassette exchange recombination into the doxycycline-inducible locus upstream of HPRT 
1
. ES cells were cultured on MEFs in DME supplemented with 15% FBS, 0.1 mM 
nonessential amino acids (GIBCO), 2 mM glutamax (Invitrogen), penicillin/streptomycin 
(Gibco), 0.1 mM β-mercaptoethanol, and 1000 U/mL LIF (Millipore), at 37°C in 5% CO2, 
and differentiated as EBs by preplating for 40 minutes to remove MEFs followed by 
suspension culture in hanging drops (100 cells per 10μL drop) in EBD medium: IMDM 
supplemented with 15% FBS, 200 μg/mL iron-saturated transferrin (Sigma), 4.5 mM 
monothiolglycerol (Sigma), 50 μg/mL ascorbic acid (Sigma), penicillin/streptomycin 
(Gibco), and 2 mM glutamax at 37°C in 5% CO2, 5% O2. After 48 hours, EBs were 
harvested from hanging drops by collecting and settling in IMDM, resuspended in 10mL of 
EBD and plated in nonadherent 10 cm dishes on a swirling rotator (1 rpm). EBs were fed 
after 48 hours by exchanging 50% of spent medium for fresh EBD medium.
Methylcellulose colony assays
For each colony assay, 50,000 cells were plated into 1.5 mL methylcellulose medium 
supplemented with IL3, IL6, Epo, and SCF (M3434, StemCell Technologies), and where 
indicated 1 μg/mL doxycycline. Primitive erythroid colonies were counted after 6 days, 
other colonies after 10 days.
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OP9 cocultures
200,000 c-Kit+/CD41+ or Flk-1+/VE-cad+ cells from day 6 EBs were purified by flow 
cytometry and plated on OP9 monolayers (50,000 OP9 cells per well preplated in 6-well 
dishes one day prior) in IMDM supplemented with 10% FBS, 5 ng/mL VEGF, 40 ng/mL 
TPO, 40 ng/mL Flt-3 ligand, penicillin/streptomycin (from 100×, Gibco), 2 mM glutamax, 
and 0.5 ug/mL doxycycline at 37°C in 5% CO2, 5% O2. Semi-adherant cells were passaged 
by trypsinization every 4-5 days and replated plated at a density of 50,000 cells per well in 
6-well dishes.
For ex vivo AGM cultures, 6 AGMs were pooled and dissociated with 0.25% Collagenase I. 
Cells were then transduced either with control (pMSCV-iresGFP) or HoxA3 retroviral 
vector (pMSCV-HoxA3-iresGFP) and cocultured on OP9 monolayers in IMDM 
supplemented with 10% FBS, 5 ng/mL VEGF, 40 ng/mL TPO, 40 ng/mL Flt-3 ligand, 5 
ng/ml IL3, 50 ng/ml Ang1, 1000 U/mL LIF (Millipore), penicillin/streptomycin (Gibco), 2 
mM glutamax, at 37°C in 5% CO2, 5% O2. Retroviral transduction of pMSCV-ires-GFP, 
MSCV-Runx1B, (kind gifts from Dr S. Tsuzuki) PU.1- (BC003815), Ikaros- (BC018349), 
Gfi1B- (BC052654) Gata1- (NM_008089.1) ires-GFP were performed on day 6 FV sorted 
progenitors. Retroviral transduction of pMSCV-ires-GFP, MSCV-Runx1B, (kind gifts from 
Dr S. Tsuzuki), MSCV-PU.1, MSCV-Ikaros, MSCV-Gata1 and MSCV-Gfi1B were 
performed as reported previously 17.
Embryo in situ hybridization
HoxA3 (Y11717) and Runx1 (BC069929) were used as templates for digoxigenin-labeled 
probes. Hybridizations were performed as described in 40. The HoxA3 knockout mice were 
kindly provided by Mario Capecchi.
Chromatin Immunoprecipitation
Chromatin Immunoprecipitation was performed by using Magna ChIP G protocol 
(Millipore). EBs were cultured as described above, and induced from day 4 to day 6. 
Between 107 and 2×107 disaggregated day 6 EB cells were crosslinked for 5 minutes with 
1% formaldehyde and lysed. Chromatin was sheared to obtain DNA fragments between 200 
and 500 bp. Immunoprecipitations used goat anti-mouse HoxA3 polyclonal (HoxA3G-14 
SC22384 Santa Cruz) and IgG control (Chrompure goat IgG) antibodies. The following 
primer sets were used for qPCR: N1: F 5′-ttggaactcttagccttgggacc-3′ R 5′-
tagatgcttcccagagaagtg-3′; N2: F 5′-tactctgggtagtccagtatttgg-3′ R 5′-
cctatgacaaaggactaatcagagtg-3′; H1: F 5′-cctctcatttcacgttgcag-3′ R 5′-ggcttcacatttggaccagt-3′; 
H2: F 5′-ttccgtaatcctggcatgcag-3′ R: 5′-agtctttgctgtgcagtttc-3′; H4: F 
5′agcagcagaagactgcagg-3′ R 5′-agtgcagatcactcgagg-3′; H5: F 5′-cctgaggatcaagctcgtgt-3′ R: 
5′-tgggtgaaaaggaggtcatc-3′
Microarray experiments
HoxA3 was induced with 1 μg/mL doxycycline in day 5 + 18 hours EBs, and cells were 
harvested 6 hours later, at day 6. 3 independent experiments were performed. cRNA was 
hybridized to MouseWG-6 Bead Chip Arrays (Illumina) and raw data were processed using 
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Beadstudio (Illumina) and analyzed on Genespring GX 7.3.1 (Agilent). For microarray 
experiments of inducible HoxA3 FV cells transduced with Gata1 or Runx1, cells were 
cultured on OP9, 5000 GFP+ cells were sorted, RNA was amplified by using SuperAmp 
(Miltenyi) amplification and Cy3- labeled cDNAs hybridized to Agilent Whole Mouse 
Genome Oligo Microarray 4 × 44K.
For qPCR validation, probes for HoxA3, Runx1, Gata1, PU.1, Ilk, Lycat, Nr2f2 and 
PlexinB1 were purchased from Applied Biosystems. Additional qPCR primers: Gfi1b 5′-
CTAGAAAGGACCGTGGCATT-3′ 5′-CAGGGACAGTGTGGAGGTTC-3′; Phemx 5′-
AGAATCTCCAGAAGGCCACC-3′ 5′-GAGCACCATAGCCACTGTGA-3′; Ikaros (Ikzf1) 
5′-GCCTTTCTGGGTAAAGGAGG-3′ 5′-TGTCCACTACCTCTGGAGCA-3′.
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Figure 1. Reciprocal expression of HoxA3 and Runx1 in embryonic endothelium
In situ hybridization of E8.25-E10.5 embryonic tissues with HoxA3 and Runx1 probes. (A-
B) HoxA3 is expressed in aortic endothelial cells, while Runx1 is not. Note that Runx1 is 
expressed in the yolk sac (black arrowheads) while HoxA3 is not. At E8.5, HoxA3 
expression (C) begins to decline in aortic endothelium, while Runx1 (D) is still not detected. 
Note that the omphalomesenteric artery, oa, is negative for HoxA3 at this time but positive 
for Runx1. (E-H) In situ hybridization of dissected E9.5 and E10.5 AGMs (shown in left 
panels). At E9.5, HoxA3 (E) expression is barely detectable in aortic endothelial cells, while 
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Runx1 (F) expression is now observed. At E10.5, HoxA3 (G) expression is completely 
extinguished in aortic endothelial cells. In contrast, Runx1 (H) expression has increased. a, 
aorta; g, gut tube; nt, neural tube; oa, omphalomesenteric artery. Stippled lines in E-H 
outline aorta. Scale bar = 50 μm for lower magnifications and AGM explants, = 10 μm for 
higher magnification panels.
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Figure 2. HoxA3 expression in early mesoderm and committed hemogenic endothelium restrains 
hematopoeisis
(A) Representative flow cytometric profiles of EBs at day 6 without doxycycline (No Dox) 
or with 1 μg/mL doxycycline (+Dox) to induce HoxA3 expression from day 4 to day 6. VE-
cadherin (VE-cad)/Flk-1 antibody staining or c-Kit/CD41 and c-Kit/CD45 staining were 
performed to identify vascular and hematopoietic progenitor populations. (B) Frequencies of 
cells expressing endothelial surface markers (Flk-1+/VE-cadherin+, F/V), hematopoietic 
markers CD41+ and CD45+ cells during EB differentiation in 7 independent experiments 
(for CD41 p=0.0004 and for CD45, p=0.0031). (C) 50,000 cells from day 6 EBs (induced 
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with 1 μg/mL dox to express HoxA3 continually from EB day 4-6 or not) were plated in 
methylcellulose with hematopoietic cytokines. n=3. Black bar: no dox treatment, gray bar: 
dox treatment. Colonies: GEMM (granulocyte/erythrocyte/macrophage/megakaryocyte) GM 
(granulocyte/macrophage) M (macrophage only) Ery-D (definitive erythroid) p=0.032, Ery-
P (primitive erythroid) p=0.0002 Ery-Meg (erythrocyte-megakaryocyte) p=0.0009. (D) 
Brightfield and fluorescence images showing both endothelial (+Dox) and hematopoietic 
colonies (No Dox or Dox removal) derived from Flk1+/VE-cadherin+ (F/V) endothelial 
progenitors from day 6 EBs. Immunofluorescence for VE-cadherin is shown in adherent 
cells growing in the presence of doxycycline. Bar 100 μm. (E) Equivalent analysis of 
cultures derived from day 6 EB c-Kit+/CD41+ (K/41) hematopoietic progenitors. (F) 
Representative flow cytometric profile of 100,000 Flk-1/VE-cadherin double positive cells 
or (G) c-Kit/CD41 double positive cells from day 6 uninduced EBs (left), cultured on OP9 
for 5 days, in the presence or absence of 1 μg/mL doxycycline. Dox-induced cells were 
cultured for an additional 4 days in the absence of dox to test the effect of HoxA3 down-
regulation. Hematopoietic surface markers, c-Kit, CD41 and CD45 and endothelial markers 
Flk-1 and VE-cadherin are plotted. (H) AGM tissue dissected from E10.5 embryos, 
dissociated and transduced with control ires-GFP or HoxA3-ires-GFP retrovirus, cultured on 
OP9 for 5 days. Bright field images are shown at left, GFP at right. Both hematopoietic and 
endothelial colonies that acquired GFP were observed with the control, but GFP segregated 
with endothelial colonies in the HoxA3-ires-GFP transduced sample, indicating skewing of 
differentiation towards endothelial by HoxA3. Bar 100 μm. (I) Representative flow 
cytometric profile of AGM cells co-cultured on OP9, and statistical analysis of 5 
independent experiments (histogram CD41 p=0.053 CD45 p=0.02).
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Figure 3. Global expression changes upon HoxA3 induction
(A) Venn diagram of regulated genes in endothelial (F/V) and hematopoietic (K/41) 
progenitor cells. Arrow up upregulated genes, arrow down downregulated genes. (B) 
Clustering of genes upregulated in the c-Kit CD41 double-positive cells upon HoxA3 
induction, during EB differentiation in the hematopoietic c-Kit CD41 double positive cells, 
based on their expression levels in the Flk-1 VE-cadherin double positive cells (F/V) and in 
the c-Kit CD41 double positive cells (K/41) of uninduced EBs. (C) Clustering of genes 
downregulated genes in the Flk-1 VE-cadherin double-positive population upon 6-hour 
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HoxA3 induction, in day 6 EB cells, based on their baseline (control) levels in the Flk-1 VE-
cadherin double-positive population (F/V). (D) Real time RTPCR measurements of gene 
expression changes following HoxA3 induction in sorted endothelial (F/V black bars) or 
hematopoietic (K/41 grey bars) progenitors. n=5 independent experiments.
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Figure 4. Global expression changes upon reversion of HoxA3 by Runx1 or Gata1
(A) Bright field (left) and fluorescent (right) images of HoxA3-induced day 6 EB-derived 
endothelial progenitors (F/V cells) transduced with control GFP vector or Runx1B-iresGFP 
retroviral vector and cultured on OP9 for 5 days. Scale bar =100 μm. (B) Representative 
flow cytometric profiles of F/V cells expressing HoxA3 and transduced with retroviral 
vectors expressing: ires-GFP (HoxA3), Ikaros (HoxA3+Ikaros), PU.1 (HoxA3+PU.1), 
Runx1-B (HoxA3+Runx1B), Gata1 (HoxA3+Gata1), Gfi1B (HoxA3+Gfi1B). GFP+ gated 
events are shown. X axis CD41, Y axis c-Kit. (C) Expression levels of hematopoietic marker 
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genes (fold of Gapdh), without HoxA3 induction (No Dox, black bars) or with HoxA3 
induction (+Dox grey bars) for control or Runx1B-transduced cells on OP9. n=3 
independent experiments. Gfi1B: p=0.0003, Ikaros: p=0.0073, Phemx: p<0.0001, PU.1: 
p=0.0009. (D) Genes upregulated by HoxA3 clustered according to their expression in 
control uninduced, HoxA3+Runx1iresGFP, HoxA3+Gata1iresGFP, and HoxA3+GFP sorted 
cells. Both Runx1 and Gata1 significantly reverse these HoxA3-induced changes, indicated 
by their clustering together and near to the non-HoxA3 expressing control. Examples are 
shown on the heat map below. (E) Genes downregulated by HoxA3. Runx1 reverses 
downregulation of HoxA3-regulated changes more effectively than Gata1, indicated by its 
clustering closest to control. Among these genes are critical endothelial regulatory factors, 
and genes involved in adhesion and cell polarity.
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Figure 5. Regulation of Runx1 by HoxA3
(A) In situ hybridization showing Runx1 expression in HoxA3 +/+, +/− and −/− E8.5 
embryos. Runx1 expression is absent in the dorsal aortae of HoxA3 +/+ (i) and HoxA3+/− 
(ii) embryos, but robustly expressed in yolk sac. Runx1 is ectopically expressed in the dorsal 
aortae of HoxA3−/− (iii) embryos. Stippled red lines outline dorsal aortae. Penetrance of this 
phenotype is indicated at lower left. (i′-iii′) Sections of the embryos shown above. Both 
endothelial and hematopoietic cells are negative for Runx1 in wild-type or heterozygous 
embryos, while Runx1-expressing cells are found in HoxA3−/− embryos. Arrows indicate 
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Runx1-expressing endothelial cells. a, aorta; ys, yolk sac. Scale bar = 50 μm for whole 
mounts, 10 μm for sections. (B) Model for regulation of endothelial hemogenesis by HoxA3 
and Runx1. HoxA3 represses a cascade of transcription factors that promote hemogenesis 
and induces a set of genes that maintain endothelial character. Runx1 is a positive regulator 
of most of these transcription factors, and a negative regulator of genes essential for 
endothelial character, thus transient expression of Runx1 erases the endothelial program and 
initiates the hematopoietic.
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